Role of Inflammatory markers in patients with breast carcinoma and their correlation with Tumor markers
Biomedicine · 10.03.2026 · 46 (1) · 62-66
DOI: 10.51248/v46i1.225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedicine, online erschienen am 10.03.2026. Verfasst von Soma Gupta und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Breast carcinoma remains a serious global health concern, with over 2.3 million women diagnosed annually and significant mortality rates persisting despite improvements in screening and treatment protocols.
Aim
This is an observational, case control, hospital-based study which was carried out to find the role of inflammatory markers in patients with breast carcinoma and their correlation with tumour markers. Metrials Methods: The study population consists of (3) three distinct study groups, Group A: patients diagnosed with breast carcinoma (n70), Group B: healthy controls (n70) and Group C: patients with benign breast disease (n70). Patients suffering from any tumor of breast identified for the first time were included in this study population. Recurrent cases were excluded from the study. Serum level of CRP and IL-6 were measured as inflammatory marker whereas CEA and CA 15 - 3 were measured as tumour markers in this study population.
Results
There was significant elevation of inflammatory markers in patients with breast carcinoma when compared to healthy control. The inflammatory markers were found to be positively correlated with patients with breast carcinoma but this correlation was not significant. Conclution: Early detection of elevated inflammatory markers could serve as a predictive tool for breast cancer prognosis. Integrating CRP and IL-6 screening in routine diagnostics may help identify high-risk patients earlier.
Zitieren
APA
Gupta, S., Mukherjee, S., & Nath, S. (2026). Role of Inflammatory markers in patients with breast carcinoma and their correlation with Tumor markers. Biomedicine, 46(1), 62-66. https://doi.org/10.51248/v46i1.225
Vancouver
Gupta S, Mukherjee S, Nath S. Role of Inflammatory markers in patients with breast carcinoma and their correlation with Tumor markers. Biomedicine. 2026;46(1):62-66. doi:10.51248/v46i1.225
BibTeX
@article{Gupta2026,
author = {Gupta, Soma and Mukherjee, Sukanya and Nath, Sukla},
title = {Role of Inflammatory markers in patients with breast carcinoma and their correlation with Tumor markers},
journal = {Biomedicine},
year = {2026},
volume = {46},
number = {1},
pages = {62--66},
doi = {10.51248/v46i1.225}
}
EUVIMED